Commerce Bank’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-333
| Closed | -$3.15K | – | 1194 |
|
2025
Q1 | $3.15K | Buy |
+333
| New | +$3.15K | ﹤0.01% | 1174 |
|
2024
Q4 | – | Sell |
-467
| Closed | -$30K | – | 1188 |
|
2024
Q3 | $30K | Hold |
467
| – | – | ﹤0.01% | 1216 |
|
2024
Q2 | $35K | Sell |
467
-66
| -12% | -$4.95K | ﹤0.01% | 1191 |
|
2024
Q1 | $63.7K | Buy |
533
+133
| +33% | +$15.9K | ﹤0.01% | 1183 |
|
2023
Q4 | $33.2K | Hold |
400
| – | – | ﹤0.01% | 1174 |
|
2023
Q3 | $31.7K | Buy |
+400
| New | +$31.7K | ﹤0.01% | 1136 |
|
2022
Q3 | – | Sell |
-48
| Closed | -$6K | – | 1141 |
|
2022
Q2 | $6K | Hold |
48
| – | – | ﹤0.01% | 1141 |
|
2022
Q1 | $10K | Hold |
48
| – | – | ﹤0.01% | 1170 |
|
2021
Q4 | $9K | Hold |
48
| – | – | ﹤0.01% | 1175 |
|
2021
Q3 | $13K | Buy |
+48
| New | +$13K | ﹤0.01% | 1158 |
|